Cocrystal Pharma (COCP) Competitors

Applied Therapeutics (NASDAQ:APLT) and Cocrystal Pharma (NASDAQ:COCP) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, media sentiment, valuation and earnings.

Which has more volatility and risk, APLT or COCP?

Applied Therapeutics has a beta of 1.97, meaning that its stock price is 97% more volatile than the S&P 500. Comparatively, Cocrystal Pharma has a beta of 2.07, meaning that its stock price is 107% more volatile than the S&P 500.

Which has preferable earnings and valuation, APLT or COCP?

Cocrystal Pharma has lower revenue, but higher earnings than Applied Therapeutics. Cocrystal Pharma is trading at a lower price-to-earnings ratio than Applied Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Therapeutics	$121K	612.35	-$105.62M	-$0.45	-1.14
Cocrystal Pharma	N/A	N/A	-$17.50M	-$1.24	-1.23

Does the media prefer APLT or COCP?

In the previous week, Applied Therapeutics had 8 more articles in the media than Cocrystal Pharma. MarketBeat recorded 16 mentions for Applied Therapeutics and 8 mentions for Cocrystal Pharma. Applied Therapeutics' average media sentiment score of 1.08 beat Cocrystal Pharma's score of 0.64 indicating that Applied Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Applied Therapeutics	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cocrystal Pharma	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate APLT or COCP?

Applied Therapeutics currently has a consensus price target of $6.10, suggesting a potential upside of 1,085.62%. Cocrystal Pharma has a consensus price target of $6.00, suggesting a potential upside of 291.90%. Given Applied Therapeutics' higher possible upside, equities analysts plainly believe Applied Therapeutics is more favorable than Cocrystal Pharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Therapeutics	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Cocrystal Pharma	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is APLT or COCP more profitable?

Cocrystal Pharma's return on equity of -144.12% beat Applied Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied Therapeutics	N/A	-354.24%	-144.16%
Cocrystal Pharma	N/A	-144.12%	-102.85%

Do institutionals and insiders have more ownership in APLT or COCP?

98.3% of Applied Therapeutics shares are held by institutional investors. Comparatively, 6.7% of Cocrystal Pharma shares are held by institutional investors. 1.6% of Applied Therapeutics shares are held by company insiders. Comparatively, 28.1% of Cocrystal Pharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Applied Therapeutics beats Cocrystal Pharma on 8 of the 14 factors compared between the two stocks.